Safety of arteriovenous fistulae and grafts for continuous renal replacement therapy: The Michigan experience

Publisher： John Wiley & Sons Inc

E-ISSN： 1542-4758|22|1|50-55

ISSN： 1492-7535

Source： Hemodialysis International, Vol.22, Iss.1, 2018-01, pp. : 50-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Using Imipenem and Cilastatin During Continuous Renal Replacement Therapy

By Cotton Alison   Franklin Bryony   Brett Stephen   Holmes Alison  

Pharmacy World and Science, Vol. 27, Iss. 5, 2005-10 ,pp. : 371-375

Springer Publishing Company

Access to resources Recommend Favorite

Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

By Isla Arantxazu  

Clinical Pharmacokinetics, Vol. 47, Iss. 3, 2008-01 ,pp. : 173-180

Adis International

Access to resources Recommend Favorite

Drug Dosing During Intermittent Hemodialysis and Continuous Renal Replacement Therapy: Special Considerations in Pediatric Patients

By Veltri M.A.  

Pediatric Drugs, Vol. 6, Iss. 1, 2004-01 ,pp. : 45-65

Adis International

Access to resources Recommend Favorite

Effects of Renal Replacement Therapy on Antimicrobial Therapy

By  

Current Clinical Pharmacology, Vol. 8, Iss. 1, 2013-02 ,pp. : 39-45

Bentham Science Publishers

Access to resources Recommend Favorite

Anticoagulation in Patients With Acute Renal Failure Treated With Continuous Renal Replacement Therapies

By  

Hemodialysis International, Vol. 2, Iss. 1, 1998-01 ,pp. : 41-59

John Wiley & Sons Inc

Access to resources Recommend Favorite